Approval · Notice of Compliance 4378 · 1996
NUROMAX: Notice of Compliance 4378
Issued April 15, 1996
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 4378
- Date
- April 15, 1996
- Company
- Glaxo Wellcome Inc.Mississauga, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Therapeutic class
- Intravenous nondepolarizing skeletal neuromuscular blocking agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| NUROMAX | 01924656 | Cancelled Post Market |
Medicinal ingredients
- DOXACURIUM CHLORIDE 1 MG per ML